AI Science Tracker
EN

Integrated Multi-Omics and Machine Learning Identify PTTG1 as a Prognostic Biomarker and Therapeutic Target in Endometrial Cancer

Affiliation not stated in the reviewed material · 3 Nov 2026 · medicine

Discovery

Integrated Multi-Omics and Machine Learning Identify PTTG1 as a Prognostic Biomarker and Therapeutic Target in Endometrial Cancer

Source check: Source checked. Not independent scientific confirmation.

Finding: A Research Square preprint integrated TCGA and GEO multi-omics data with machine-learning feature selection to identify PTTG1 as a prognostic candidate in endometrial cancer. The authors report expression and protein-level checks in paired clinical specimens and CPTAC corroboration. This does not establish clinical utility or therapeutic efficacy.

Technology: Integrated multi-omics analysis with machine-learning prognostic modeling

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
LASSO, SVM-RFE, XGBoost and Boruta were used for feature selection in TCGA/GEO transcriptomic analyses; single-cell and spatial transcriptomics informed localization of PTTG1.
Test and result
The preprint reports PTTG1 expression checks with Western blot, qRT-PCR and immunohistochemistry in paired clinical specimens, and CPTAC proteomic corroboration.
Limitation / still unknown
The reported specimen checks do not establish clinical utility or therapeutic efficacy; independent prospective validation is not reported.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.researchsquare.com/article/rs-10764988/v1 · https://europepmc.org/article/PPR/PPR1356426

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.